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arly Growth Response Factor-1*
ohn A. Elefteriades, MD, FACC,
ichael J. Collins, MD
ew Haven, Connecticut
neurysm rupture is a potentially devastating complication
f abdominal aortic aneurysms; however, the events leading
o rupture remain unclear. It has been suggested that mural
hrombus may play a role in this process (1). In this issue of
he Journal, Shin et al. (2) examine the role of early growth
esponse factor (Egr)-1 and tissue factor (TF) (a prothrom-
otic factor) in thrombus formation. In human aneurysmal
issue, they observe (using quantitative polymerase chain
eaction and immunohistochemistry) increased amounts of
gr-1 and TF in the thrombus-covered wall compared with
he thrombus-free wall. They show that in tissue culture,
verexpression of Egr-1 results in TF up-regulation. Lastly,
hey confirm that overexpression of Egr-1 promotes throm-
us formation in a mouse vena cava ligation model. The
uthors conclude that Egr-1 is up-regulated in the human
hrombus-covered aneurysm wall and that Egr-1 may play
n early role in thrombus formation and, potentially, aneu-
ysm rupture.
See page 792
The paper by Shin et al. (2) is an exceptional contribu-
ion, which really represents multiple studies in 1 beautifully
ntegrated whole. The 3 components—the assay of Egr-1 in
uman aneurysm tissue, the tranfection cell culture, and the
ena caval thrombosis observations—are beautifully planned
nd coordinated. The use of multiple models (cell culture,
nimal models, and aneurysmal human tissue) provides
owerful evidence for the importance of Egr-1 in aneurysm
athogenesis. Each phase of the study has thoughtful,
onvincing control interventions, solidifying the importance
f Egr-1 rather than other potential influences. However, it
emains unclear whether differences in Egr-1 expression are
rimary forces or epiphenomena. The authors touch on this
oint in their Discussion section. Even if these are epiphe-
omena, the authors’ observations still contribute to our
nderstanding.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
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From the Department of Surgery, Cardiothoracic Surgery, Yale University School
f Medicine, New Haven, Connecticut.From the standpoint of a practicing aortic surgeon, it is
mportant to emphasize that we see thrombus clinically only
f there is significant dilation of a portion of the descending
orta. When the dilation is eccentric, the thrombus is
imited to the most dilated portion, even if it affects only
art of the circumference of the aorta. The surgeon under-
tands this localization (rightly or not) as a consequence of
lower flow in the eccentrically dilated portions of the aorta.
t is well known that slow-flowing blood clots. Only the
entral portion of a severely dilated aorta has rapid, laminar
ow. The authors touch on these anatomic and fluid
ynamics issues in their Discussion section. It could well be
hat all changes in Egr-1 expression seen by the authors
imply are downstream consequences of the basic principle
hat slow-flowing blood clots. This is, after all, the body’s
echanism for sealing wounds. While the slow-flowing
ypothesis could explain the thrombus, is there any way by
hich slow blood flow per se could lead directly to altered
xpression of Egr-1 in the aortic wall?
From a surgeon’s viewpoint, it is important to also
ention that thrombus is almost never seen in the ascend-
ng aorta, despite severe dilation (3). We have simplistically
resumed that the ascending aorta is so thoroughly
washed” by blood flow that thrombus does not have a
hance to form. Furthermore, a number of recent studies
ave demonstrated differences in gene expression between
neurysmal tissue in the abdominal aorta compared with
hat in the ascending aorta (4). These molecular studies,
ncluding the present report, combined with anatomic and
athological findings, suggest that aneurysms of the aorta
ay develop through different mechanisms in the ascending
nd descending/abdominal aortic segments.
The role of thrombus formation in abdominal aneurysm
athogenesis and rupture remains unclear. In the current
eport, the authors imply that—because of the involvement
f Egr-1 in thrombosis and potentially in rupture—we
ight, therefore, want to stop thrombosis in an aneurysm.
owever, the potential benefit of this is not intuitively clear.
lthough embolization of thrombotic material does occa-
ionally occur, this complication pales in comparison to
atastrophic rupture in frequency and impact. Furthermore,
hile thrombus is often found at the site of rupture (5),
here is no direct evidence that the thrombus promotes
upture. Is it not simply much more likely that thrombus
nd rupture both occur at the most dilated and mechanically
eakened portion of the aortic wall?
Lastly, though the authors may have intended to use
nowledge of the Egr-1 biology in monitoring an aneurysm
atient’s status and specific risk for rupture, this appears
nlikely to be feasible at the present time. As with other
olecular markers for aneurysm growth, any such applica-
ion is limited by the simple fact that we cannot really biopsy
he aortic wall sequentially in monitoring patients. This point
ighlights the need to identify systemic markers of aneurysm
ctivity that can be assessed through peripheral blood drawing.
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March 3, 2009:800–1 Early Growth Response Factor-1All in all, the authors provide a new perspective, centered
round the phenomenon of localized thrombosis within
neurysms, which augments our understanding of the over-
ll pathobiology of aneurysm disease.
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